Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliane S Walz

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Der Internist|August 16, 2021
[Tumor vaccination-strategies and time points]Yacine Maringer, Juliane S Walz
Frontiers in Immunology|January 11, 2020
Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy?Malte Roerden, Annika Nelde, Juliane S Walz
Molecular & Cellular Proteomics : MCP|February 15, 2021
The Peptide Vaccine of the FutureAnnika Nelde, Hans-Georg Rammensee, Juliane S Walz
Seminars in Immunology|January 27, 2023
Viral T-cell epitopes - Identification, characterization and clinical applicationSarah M Schroeder, Annika Nelde, Juliane S Walz
International Journal of Molecular Sciences|March 23, 2019
Antigen Targets for the Development of Immunotherapies in LeukemiaJens Bauer, Annika Nelde, Tatjana Bilich, et al.
Viruses|October 28, 2023
Long-Term Follow-Up of COVID-19 Convalescents-Immune Response Associated with Reinfection Rate and SymptomsAnna Seller, Christopher Hackenbruch, Juliane S Walz, et al.
Cancers|October 14, 2022
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease OutcomeMaddalena Marconato, Yacine Maringer, Juliane S Walz, et al.
Annals of Hematology|January 4, 2020
Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experienceMalte Roerden, Martin Sökler, Lothar Kanz, et al.
Cancers|June 2, 2021
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose ChemotherapyMalte Roerden, Stefan Wirths, Martin Sökler, et al.
Wellcome Open Research|May 27, 2024
Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C MoleculesArwen F Altenburg, Jack L Morley, Jens Bauer, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Der Internist|August 16, 2021
[Tumor vaccination-strategies and time points]Yacine Maringer, Juliane S Walz
Frontiers in Immunology|January 11, 2020
Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy?Malte Roerden, Annika Nelde, Juliane S Walz
Molecular & Cellular Proteomics : MCP|February 15, 2021
The Peptide Vaccine of the FutureAnnika Nelde, Hans-Georg Rammensee, Juliane S Walz
Seminars in Immunology|January 27, 2023
Viral T-cell epitopes - Identification, characterization and clinical applicationSarah M Schroeder, Annika Nelde, Juliane S Walz
International Journal of Molecular Sciences|March 23, 2019
Antigen Targets for the Development of Immunotherapies in LeukemiaJens Bauer, Annika Nelde, Tatjana Bilich, et al.
Viruses|October 28, 2023
Long-Term Follow-Up of COVID-19 Convalescents-Immune Response Associated with Reinfection Rate and SymptomsAnna Seller, Christopher Hackenbruch, Juliane S Walz, et al.
Cancers|October 14, 2022
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease OutcomeMaddalena Marconato, Yacine Maringer, Juliane S Walz, et al.
Annals of Hematology|January 4, 2020
Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experienceMalte Roerden, Martin Sökler, Lothar Kanz, et al.
Cancers|June 2, 2021
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose ChemotherapyMalte Roerden, Stefan Wirths, Martin Sökler, et al.
Wellcome Open Research|May 27, 2024
Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C MoleculesArwen F Altenburg, Jack L Morley, Jens Bauer, et al.
Pageof 8